Financials
Value Q1, 25Q2, 25 TTM Selling/general/admin expenses 871.7 M843.4 M 3.35 B Research & development —— — Operating income 198.7 M122.2 M 698.9 M Non-Operating Income, Total 37.1 M20.4 M 49.6 M Interest expense, net of interest capitalized 13.1 M12.9 M 51.9 M Non-Operating Income, excl. Interest Expenses -18.6 M-5.4 M -60.6 M Unusual income/expense 42.6 M12.9 M 58.3 M Pretax income 228.2 M122.2 M 705.3 M Equity in earnings —— — Taxes 51.1 M27.4 M 151.2 M Non-controlling/minority interest —— — After tax other income/expense —— — Net income before discontinued operations 177.1 M94.8 M 554.1 M Discontinued operations -1.3 M-7.5 M 85.1 M Net income 175.8 M87.3 M 639.2 M Dilution adjustment —— — Preferred dividends —— — Diluted net income available to common stockholders 175.8 M87.3 M 639.2 M Basic earnings per share (Basic EPS) 0.450.23 1.63 Diluted earnings per share (Diluted EPS) 0.450.22 1.61 Average basic shares outstanding 389.91 M385.98 M — Diluted shares outstanding 394.2 M389.63 M — EBITDA 322.4 M177.9 M 966.7 M EBIT 266.8 M120.7 M 747.2 M Cost of revenue 664.2 M582.9 M 2.53 B Other cost of goods sold —— — Depreciation & amortization (cash flow) 55.6 M57.2 M 219.5 M